Global Infantile Spasms Therapeutics Market Professional Survey Report 2017

December 2017 | 126 pages | ID: GEECE77BD14EN
QYResearch

Abstracts

In the last several years, global market of Infantile Spasms Therapeutics developed steadily, with an average growth rate of 2.9%. In 2016, global revenue of Infantile Spasms Therapeutics is nearly 130 million USD; the actual production is about 6340 units.

This report studies Infantile Spasms Therapeutics in Global market, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Mallinckrodt
• H. Lundbeck
• Insys Therapeutics
• Orphelia Pharma
• Valerion Therapeutics
• Catalyst Pharmaceuticals
• Anavex Life Sciences
• Retrophin
• GW Pharmaceuticals

Market Segment by Regions, this report splits Global into several key Regions, with production, sales, revenue, and market share and growth rate of Infantile Spasms Therapeutics in these regions, from 2012 to 2022 (forecast), like

• United States
• Europe
• China
• Japan
• RoA
• RoW

Split by Product Type, with production, revenue, price, and market share and growth rate of each type, can be divided into

• Oral
• Injection

Split by application, this report focuses on sales, market share and growth rate of Infantile Spasms Therapeutics in each application, can be divided into

• Hospital
• Clinic
• Other

Note: RoW: Rest of World, RoA: Rest of Asia

Contents

1 INDUSTRY OVERVIEW OF INFANTILE SPASMS THERAPEUTICS

1.1 Definition and Specifications of Infantile Spasms Therapeutics
1.2 Infantile Spasms Therapeutics Segment by Types (Product Category)
  1.2.1 Global Infantile Spasms Therapeutics Production and Growth Rate (%) Comparison by Types (2012-2022)
  1.2.2 Global Infantile Spasms Therapeutics Production Market Share (%) by Types in 2016
  1.2.3 Oral
  1.2.4 Injection
1.3 Global Infantile Spasms Therapeutics Segment by Applications
  1.3.1 Global Infantile Spasms Therapeutics Consumption Comparison by Applications (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
1.4 Global Infantile Spasms Therapeutics Market by Regions
  1.4.1 Global Infantile Spasms Therapeutics Market Size and Growth Rate Comparison by Regions (2012-2022)
  1.4.2 United States Infantile Spasms Therapeutics Status and Prospect (2012-2017)
  1.4.3 China Infantile Spasms Therapeutics Status and Prospect (2012-2017)
  1.4.4 Europe Infantile Spasms Therapeutics Status and Prospect (2012-2017)
  1.4.5 Japan Infantile Spasms Therapeutics Status and Prospect (2012-2017)
  1.4.6 RoA Infantile Spasms Therapeutics Status and Prospect (2012-2017)
  1.4.7 RoW Infantile Spasms Therapeutics Status and Prospect (2012-2017)
1.5 Global Infantile Spasms Therapeutics Market Size (2012-2017)
  1.5.1 Global Infantile Spasms Therapeutics Sales Revenue Status and Outlook (2012-2017)
  1.5.2 Global Infantile Spasms Therapeutics Capacity, Production Status and Outlook (2012-2017)

2 MANUFACTURING COST STRUCTURE ANALYSIS OF INFANTILE SPASMS THERAPEUTICS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Infantile Spasms Therapeutics
  2.2.1 Raw Materials
  2.2.2 Labor Cost Analysis
  2.2.3 Other Costs Analysis
2.3 Manufacturing Process Analysis of Infantile Spasms Therapeutics
2.4 Industry Chain Structure of Infantile Spasms Therapeutics
  2.4.1 Infantile Spasms Therapeutics R&D Cost Analysis
  2.4.2 Clinical Phase Costs
  2.4.3 Capitalized Costs
2.5 Technology Progress
2.6 Economic/Political Environmental Change

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF INFANTILE SPASMS THERAPEUTICS

3.1 Capacity and Founded Date of Global Infantile Spasms Therapeutics Major Manufacturers in 2016
3.2 Headquarter of Global Infantile Spasms Therapeutics Major Manufacturers in 2016
3.3 Product Brands of Global Infantile Spasms Therapeutics Major Manufacturers in 2016
3.4 Mergers & Acquisitions, Expansion
3.5 FDA Approvals

4 GLOBAL INFANTILE SPASMS THERAPEUTICS OVERALL MARKET OVERVIEW

4.1 2012-2017 Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017 Global Infantile Spasms Therapeutics Capacity and Growth Rate Analysis
  4.2.2 2016 Infantile Spasms Therapeutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017 Global Infantile Spasms Therapeutics Sales and Growth Rate Analysis
  4.3.2 2016 Infantile Spasms Therapeutics Sales Analysis (Company Segment)
4.4 Ex-factory Price Analysis
  4.4.1 2012-2017 Global Infantile Spasms Therapeutics Ex-factory Price
  4.4.2 2016 Infantile Spasms Therapeutics Ex-factory Price Analysis (Company Segment)

5 INFANTILE SPASMS THERAPEUTICS REGIONAL MARKET ANALYSIS

5.1 United States Infantile Spasms Therapeutics Market Analysis
  5.1.1 United States Infantile Spasms Therapeutics Market Overview
  5.1.2 United States 2012-2017 Infantile Spasms Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 United States 2012-2017 Infantile Spasms Therapeutics Sales Price Analysis
  5.1.4 United States 2016 Infantile Spasms Therapeutics Market Share Analysis
5.2 China Infantile Spasms Therapeutics Market Analysis
  5.2.1 China Infantile Spasms Therapeutics Market Overview
  5.2.2 China 2012-2017 Infantile Spasms Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017 Infantile Spasms Therapeutics Sales Price Analysis
  5.2.4 China 2016 Infantile Spasms Therapeutics Market Share Analysis
5.3 Europe Infantile Spasms Therapeutics Market Analysis
  5.3.1 Europe Infantile Spasms Therapeutics Market Overview
  5.3.2 Europe 2012-2017 Infantile Spasms Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017 Infantile Spasms Therapeutics Sales Price Analysis
  5.3.4 Europe 2016 Infantile Spasms Therapeutics Market Share Analysis
5.4 Japan Infantile Spasms Therapeutics Market Analysis
  5.4.1 Japan Infantile Spasms Therapeutics Market Overview
  5.4.2 Japan 2012-2017 Infantile Spasms Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Japan 2012-2017 Infantile Spasms Therapeutics Sales Price Analysis
  5.4.4 Japan 2016 Infantile Spasms Therapeutics Market Share Analysis
5.5 RoA Infantile Spasms Therapeutics Market Analysis
  5.5.1 RoA Infantile Spasms Therapeutics Market Overview
  5.5.2 RoA 2012-2017 Infantile Spasms Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 RoA 2012-2017 Infantile Spasms Therapeutics Sales Price Analysis
  5.5.4 RoA 2016 Infantile Spasms Therapeutics Market Share Analysis
5.6 RoW Infantile Spasms Therapeutics Market Analysis
  5.6.1 RoW Infantile Spasms Therapeutics Market Overview
  5.6.2 RoW 2012-2017 Infantile Spasms Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 RoW 2012-2017 Infantile Spasms Therapeutics Sales Price Analysis
  5.6.4 RoW 2016 Infantile Spasms Therapeutics Market Share Analysis

6 GLOBAL 2012-2017 INFANTILE SPASMS THERAPEUTICS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017 Infantile Spasms Therapeutics Sales by Type
6.2 Different Types Infantile Spasms Therapeutics Product Interview Price Analysis
6.3 Different Types Infantile Spasms Therapeutics Product Driving Factors Analysis
  6.3.1 Oral Growth Rate Analysis
  6.3.2 Injection Growth Rate Analysis
6.4 Different Types Infantile Spasms Therapeutics Product Driving Factors Analysis

7 GLOBAL 2012-2017 INFANTILE SPASMS THERAPEUTICS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017 Infantile Spasms Therapeutics Consumption by Application
7.2 Different Application Infantile Spasms Therapeutics Product Interview Price Analysis
7.3 Different Application Infantile Spasms Therapeutics Product Driving Factors Analysis
  7.3.1 Hospital Growth Rate Analysis
  7.3.2 Clinic Growth Rate Analysis
7.4 Different Application Infantile Spasms Therapeutics Product Driving Factors Analysis

8 ANALYSIS OF INFANTILE SPASMS THERAPEUTICS INDUSTRY KEY MANUFACTURERS

8.1 Mallinckrodt
  8.1.1 Company Profile
  8.1.2 Product Information
  8.1.3 Sales, Price, Cost, Gross, and Revenue
  8.1.4 Mallinckrodt 2016 Nitinol-based Medical Device Business Region Distribution Analysis
8.2 H. Lundbeck
  8.2.1 Company Profile
  8.2.2 Product Information
  8.2.3 Sales, Price, Cost, Gross, and Revenue
  8.2.4 H. Lundbeck 2016 Nitinol-based Medical Device Business Region Distribution Analysis
8.2 Insys Therapeutics
  8.2.1 Company Profile
  8.2.2 Product Information
8.4 Orphelia Pharma
  8.4.1 Company Profile
  8.4.2 Product Information
8.5 Valerion Therapeutics
  8.5.1 Company Profile
8.6 Catalyst Pharmaceuticals
  8.6.1 Company Profile
  8.6.2 Product Information
8.7 Anavex Life Sciences
  8.7.1 Company Profile
  8.7.2 Product Information
8.8 Retrophin
  8.8.1 Company Profile
8.9 GW Pharmaceuticals
  8.9.1 Company Profile
  8.9.2 Product Information

9 DEVELOPMENT TREND OF ANALYSIS OF INFANTILE SPASMS THERAPEUTICS MARKET

9.1 Global Infantile Spasms Therapeutics Market Trend Analysis
  9.1.1 Global 2017-2022 Infantile Spasms Therapeutics Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Infantile Spasms Therapeutics Ex-factory Price Forecast
9.2 Infantile Spasms Therapeutics Regional Market Trend
  9.2.1 United States 2017-2022 Infantile Spasms Therapeutics Consumption Forecast
  9.2.2 China 2017-2022 Infantile Spasms Therapeutics Consumption Forecast
  9.2.3 Europe 2017-2022 Infantile Spasms Therapeutics Consumption Forecast
  9.2.4 Japan 2017-2022 Infantile Spasms Therapeutics Consumption Forecast
  9.2.5 RoA 2017-2022 Infantile Spasms Therapeutics Consumption Forecast
  9.2.6 RoW 2017-2022 Infantile Spasms Therapeutics Consumption Forecast
9.3 Infantile Spasms Therapeutics Market Trend (Product Type)
9.4 Infantile Spasms Therapeutics Market Trend (Application)

10 INFANTILE SPASMS THERAPEUTICS MARKETING TYPE ANALYSIS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
10.3 Traders or Distributors with Contact Information of Infantile Spasms Therapeutics

11 CONSUMERS ANALYSIS OF INFANTILE SPASMS THERAPEUTICS

11.1 Mayo Clinic Analysis
11.2 Boston Children's Hospital Analysis
11.3 Royal Brompton Hospital Analysis
11.4 Johns Hopkins Hospital Analysis
11.5 Ohio State University Wexner Medical Center
11.6 University of Iowa Hospitals and Clinics

12 CONCLUSION OF THE INFANTILE SPASMS THERAPEUTICS MARKET

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Infantile Spasms Therapeutics
Table Global Infantile Spasms Therapeutics Production (Unit) and Growth Rate (%) Comparison by Types (2012-2022)
Figure Global Infantile Spasms Therapeutics Production Market Share (%) by Types in 2016
Figure Product Picture of Oral
Figure Product Picture of Injection
Table Global Infantile Spasms Therapeutics Consumption (Unit) Comparison by Applications (2012-2022)
Figure Global Infantile Spasms Therapeutics Consumption Market Share (%) by Applications in 2016
Figure Hospitals Examples
Figure Clinics Examples
Table Global Infantile Spasms Therapeutics Sales (Unit) Comparison by Regions (2012-2022)
Figure United States Infantile Spasms Therapeutics Sales Revenue (M USD) and Growth Rate (2012-2017)
Figure China Infantile Spasms Therapeutics Sales Revenue (M USD) and Growth Rate (2012-2017)
Figure Europe Infantile Spasms Therapeutics Sales Revenue (M USD) and Growth Rate (2012-2017)
Figure Japan Infantile Spasms Therapeutics Sales Revenue (M USD) and Growth Rate (2012-2022)
Figure RoA Infantile Spasms Therapeutics Sales Revenue (M USD) and Growth Rate (2012-2017)
Figure RoW Infantile Spasms Therapeutics Sales Revenue (M USD) and Growth Rate (2012-2017)
Figure Global Infantile Spasms Therapeutics Sales Revenue (M USD) Status and Outlook (2012-2017)
Figure Global Infantile Spasms Therapeutics Capacity (Unit) Status and Outlook (2012-2017)
Figure Global Infantile Spasms Therapeutics Production (Unit) Status and Outlook (2012-2017)
Table Infantile Spasms Therapeutics Raw Material and Suppliers
Table Raw Material Suppliers Analysis and Contact Information
Figure Manufacturing Cost Structure Analysis of Infantile Spasms Therapeutics in 2016
Figure USA Labor Cost Analysis 2012-2016
Figure Cost of Employing a Factory Worker
Figure 2016 Estimated Labour Costs for the Whole Economy in Europe
Figure Monthly Minimum Wages in Asia 2016
Figure China Labor Costs 2013-2016
Table Average Price of Electricity to Ultimate Customers 2007-2016
Figure Electricity Prices for Household Consumers in 2016
Figure Summary of the Driving Assumptions
Figure Industrial Electric Rates 2016 (PER KWH)
Figure Manufacturing Process Analysis of Infantile Spasms Therapeutics
Figure Typical Phases from Research to the Market for a Drug Candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure Global GDP Map 2016
Figure EU GDP Change 2006-2016
Figure Germany CPI Change 2016-2017
Figure UK CPI Change 2007-2016
Figure Japan GDP Change 2014-2017
Figure Japan CPI Change in 2016
Figure China GDP Change 2014-2017
Figure China CPI Change 2016-2017
Figure US GDP Change 2013-2016
Figure US CPI Change 2016-2017
Table Capacity (Unit) and Founded Date of Global Infantile Spasms Therapeutics Major Manufacturers in 2016
Table Headquarter of Global Infantile Spasms Therapeutics Major Manufacturers in 2016
Table Manufacturers Infantile Spasms Therapeutics Product Brands
Table Mergers & Acquisitions, Expansion
Table H.P. Acthar Gel FDA Approvals Introduction
Table Sabril (vigabatrin) FDA Approvals Introduction
Table Global Capacity (Unit), Sales (Unit), Price (K USD/Unit), Cost (K USD/Unit), Sales Revenue (M USD) and Gross Margin of Infantile Spasms Therapeutics 2012-2017
Figure Global 2012-2017 Infantile Spasms Therapeutics Sales (Unit) and Growth Rate
Figure Global 2012-2017 Infantile Spasms Therapeutics Revenue Market Size (M USD) and Growth Rate
Figure 2012-2017 Global Infantile Spasms Therapeutics Capacity and Growth Rate
Table 2016 Global Infantile Spasms Therapeutics Capacity (Unit) List (Company Segment)
Figure 2012-2017 Global Infantile Spasms Therapeutics Sales (Unit) and Growth Rate
Table 2016 Global Infantile Spasms Therapeutics Sales (Unit) List (Company Segment)
Figure 2012-2017 Global Infantile Spasms Therapeutics Ex-factory Price (K USD/Unit)
Table 2016 Global Infantile Spasms Therapeutics Ex-factory Price (K USD/Unit) List (Company Segment)
Table United States Supply, Consumption Overview (Unit)
Table United States Supply, Import, Export and Consumption of Infantile Spasms Therapeutics 2012-2017 (Unit)
Figure United States 2012-2017 Infantile Spasms Therapeutics Sales Price (K USD/Unit)
Figure United States 2016 Infantile Spasms Therapeutics Sales Market Share
Table China Supply, Consumption Overview (Unit)
Table China Supply, Import, Export and Consumption of Infantile Spasms Therapeutics 2012-2017 (Unit)
Figure China 2012-2017 Infantile Spasms Therapeutics Sales Price (K USD/Unit)
Table China 2016 Infantile Spasms Therapeutics Sales (Unit)
Table Europe Supply, Consumption Overview (Unit)
Table Europe Supply, Import, Export and Consumption of Infantile Spasms Therapeutics 2012-2017 (Unit)
Figure Europe 2012-2017 Infantile Spasms Therapeutics Sales Price (K USD/Unit)
Figure Europe 2016 Infantile Spasms Therapeutics Sales Market Share
Table Japan Supply, Consumption Overview (Unit)
Table Japan Supply, Import, Export and Consumption of Infantile Spasms Therapeutics 2012-2017 (Unit)
Figure Japan 2012-2017 Infantile Spasms Therapeutics Sales Price (K USD/Unit)
Table Japan 2016 Infantile Spasms Therapeutics Sales (Unit)
Table RoA Supply, Consumption Overview (Unit)
Table RoA Supply, Import, Export and Consumption of Infantile Spasms Therapeutics 2012-2017 (Unit)
Figure RoA 2012-2017 Infantile Spasms Therapeutics Sales Price (K USD/Unit)
Table RoA 2016 Infantile Spasms Therapeutics Sales (Unit)
Table RoW Supply, Consumption Overview (Unit)
Table RoW Supply, Import, Export and Consumption of Infantile Spasms Therapeutics 2012-2017 (Unit)
Figure RoW 2012-2017 Infantile Spasms Therapeutics Sales Price (K USD/Unit)
Table RoW 2016 Infantile Spasms Therapeutics Sales (Unit)
Table Global 2012-2017 Infantile Spasms Therapeutics Sales (Unit) by Type
Table Different Types Infantile Spasms Therapeutics Product Interview Price
Figure Oral Growth Rate Analysis
Figure Injection Growth Rate Analysis
Table Global 2012-2017 Infantile Spasms Therapeutics Sales (Unit) by Application
Table Different Application Infantile Spasms Therapeutics Product Interview Price
Figure Hospital Growth Rate Analysis
Figure Clinic Growth Rate Analysis
Figure Global New Born
Table Mallinckrodt Company Profile
Figure Infantile Spasms Therapeutics Product Introduction of Mallinckrodt
Table Infantile Spasms Therapeutics Sales (Unit), Price (K USD/Unit), Cost (K USD/Unit), Gross (K USD/Unit), Revenue (M USD) and Gross Margin of Mallinckrodt 2016-2017
Figure 2016 Mallinckrodt Nitinol-based Medical Device Business Region Distribution
Table H. Lundbeck Company Profile
Figure Infantile Spasms Therapeutics Product Introduction of H. Lundbeck
Table Infantile Spasms Therapeutics Sales (Unit), Price (K USD/Unit), Cost (K USD/Unit), Gross (K USD/Unit), Revenue (M USD) and Gross Margin of H. Lundbeck 2016-2017
Figure 2016 H. Lundbeck Nitinol-based Medical Device Business Region Distribution
Table Insys Therapeutics Company Profile
Figure Infantile Spasms Therapeutics Product Introduction of Insys Therapeutics
Table Orphelia Pharma Company Profile
Table Valerion Therapeutics Company Profile
Table Catalyst Pharmaceuticals Company Profile
Figure Infantile Spasms Therapeutics Product Introduction of Catalyst Pharmaceuticals
Table Anavex Life Sciences Company Profile
Figure Infantile Spasms Therapeutics Product Introduction of Anavex Life Sciences
Table Retrophin Company Profile
Table GW Pharmaceuticals Company Profile
Figure Infantile Spasms Therapeutics Product Introduction of GW Pharmaceuticals
Figure Global 2017-2022 Infantile Spasms Therapeutics Sales (Unit) and Growth Rate Forecast
Figure Global 2017-2022 Infantile Spasms Therapeutics Market Size (M USD) and Growth Rate Forecast
Figure Global 2017-2022 Infantile Spasms Therapeutics Ex-factory Price (K USD/Unit) Forecast
Figure United States 2017-2022 Infantile Spasms Therapeutics Consumption Volume and Growth Rate Forecast
Figure China 2017-2022 Infantile Spasms Therapeutics Consumption Volume and Growth Rate Forecast
Figure Europe 2017-2022 Infantile Spasms Therapeutics Consumption Volume and Growth Rate Forecast
Figure Japan 2017-2022 Infantile Spasms Therapeutics Consumption Volume and Growth Rate Forecast
Figure RoA 2017-2022 Infantile Spasms Therapeutics Consumption Volume and Growth Rate Forecast
Figure RoW 2017-2022 Infantile Spasms Therapeutics Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (Unit) of Infantile Spasms Therapeutics by Type 2017-2022
Table Global Sales Volume Market Share of Infantile Spasms Therapeutics by Type 2017-2022
Table Global Consumption Volume (Unit) of Infantile Spasms Therapeutics by Application 2017-2022
Table Global Consumption Volume Market Share of Infantile Spasms Therapeutics by Application 2017-2022
Figure Market Channel of Infantile Spasms Therapeutics
Table Traders or Distributors with Contact Information of Infantile Spasms Therapeutics
Table Mayo Clinic Information List
Table Boston Children's Hospital Information List
Table Royal Brompton Hospital Information List
Table Johns Hopkins Hospital Information List
Table Ohio State University Wexner Medical Center Information List
Table University of Iowa Hospitals and ClinicsInformation List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources